Sa. Cannistra et al., BINDING OF OVARIAN-CANCER CELLS TO PERITONEAL MESOTHELIUM IN-VITRO ISPARTLY MEDIATED BY CD44H, Cancer research, 53(16), 1993, pp. 3830-3838
Epithelial cancer of the ovary spreads by implantation of tumor cells
onto the mesothelial lining of the peritoneal cavity. We have develope
d an in vitro binding assay using confluent monolayers of normal perit
oneal mesothelial cells in order to assess the role of known adhesion
proteins in this process. Cells from normal ovarian surface epithelium
, and the ovarian cancer cell lines CAOV-3 and SKOV-3 exhibited signif
icant adhesion to mesothelium in vitro (range 33-56% specific binding)
. Although these cells expressed several adhesion molecules, including
CD44 and integrins such as alpha4beta1, alpha5beta1, and alphanubeta3
, only anti-CD44 antibody was capable of inhibiting mesothelial bindin
g (range 42-44% inhibition). Adhesion molecule expression was also det
ermined for fresh ovarian specimens, with CD44 being expressed in 2 of
2 cases of normal ovarian epithelium, 15 of 16 (94%) cases of tissue-
derived tumor (from primary sites or peritoneal implants), and only 2
of 8 (25%) cases of free-floating tumor cells from ascites. Three of t
hree CD44-positive cases derived from peritoneal implants exhibited si
gnificant mesothelial binding which was partly blocked by anti-CD44 an
tibody, whereas 2 of 2 CD44-negative cases derived from ascites showed
minimal binding. CD44-mediated binding of ovarian cancer cells was de
termined to be due to recognition of mesothelium-associated hyaluronat
e, suggesting that the CD44H isoform was involved in this process. Imm
unoprecipitation of the CD44 species expressed by ovarian cancer cells
revealed 2 major bands at 85-90 and 180 kDa, consistent with the know
n molecular masses of CD44H. These results suggest that CD44H may be a
n important mediator of ovarian cancer cell implantation and that decr
eased CD44H expression may be associated with release of cells into th
e peritoneal space during ascites formation. It is possible that strat
egies to interfere with CD44H function may result in decreased intraab
dominal spread of this highly lethal neoplasm.